What is electroCore, Inc. (ECOR) stock price today?

electroCore, Inc. (ECOR) is currently trading at $9.66, up 1.58% today.

What is ECOR P/E ratio?

electroCore, Inc.'s P/E ratio is -5.72. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ECOR return on equity (ROE)?

electroCore, Inc.'s return on equity (ROE) is 524.69%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is electroCore, Inc.'s market cap?

electroCore, Inc. has a market capitalization of $87.09M.

NCM · Medical - Devices

electroCore, Inc. (ECOR) Stock

$9.66 +1.58% NCM: ECOR Healthcare

Valuation

Metric	Value
Price	$9.66
Market Cap	$87.09M
P/E Ratio	-5.72
P/B Ratio	-32.76
P/S Ratio	2.37
EPS (TTM)	$-1.65
52-Week High	$12.70
52-Week Low	$4.41
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	524.69%
ROA	-86.56%
ROCE	-258.13%
Gross Margin	-40.62%
Operating Margin	-40.62%
Net Margin	-39.96%
Debt/Equity	-3.43
Current Ratio	1.09

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$5.0M	$9.0M	$16.0M	$25.0M	$32.0M
Operating Profit	$-20.0M	$-23.0M	$-19.0M	$-12.0M	$-13.0M
Net Profit	$-17.0M	$-22.0M	$-19.0M	$-12.0M	$-14.0M
EPS	$-4.36	$-4.69	$-3.42	$-1.59	$-1.65
Op Margin	-367.7%	-266.2%	-117.3%	-48.3%	-41.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$43.0M	$25.0M	$16.0M	$20.0M	$19.0M
Total Liabilities	$6.0M	$8.0M	$9.0M	$13.0M	$20.0M
Cash	$35.0M	$18.0M	$10.0M	$3.0M	$7.0M
Borrowings	$1.0M	$1.0M	$1.0M	$4.0M	$9.0M

Latest News

New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation GlobeNewswire · Jul 16, 2026 iAccess Alpha Virtual Best Ideas Summer Investment Conference Begins Today ACCESS Newswire · Jun 23, 2026 iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 23–24, 2026 ACCESS Newswire · Jun 18, 2026 electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference GlobeNewswire · Jun 17, 2026 Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-14.0M	$-17.0M	$-15.0M	$-7.0M	$-8.0M
Investing Cash Flow	$18.0M	$0	$0	$-9.0M	$4.0M
Financing Cash Flow	$0	$0	$-1.0M	$0	$0
Net Cash Flow	$30.0M	$-17.0M	$-7.0M	$-7.0M	$3.0M
Free Cash Flow	$-14.0M	$-17.0M	$-15.0M	$-7.0M	$-8.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	1.38
EV / EBITDA	-7.10
FCF Yield	-11.12%
Quick Ratio	1.00
Interest Coverage	-11.88
Return 1Y	-13.38%
Return 3Y	32.02%
Return 5Y	-60.65%

Ownership

Insiders Held33.33%

Institutions Held8.44%

Institutions Float Held12.66%

Institutional Holder	Shares	Report Date
Vanguard Capital Management LLC	202,644	2026-03-31
Balyasny Asset Management LP	116,463	2026-03-31
Geode Capital Management, LLC	78,083	2026-03-31
Jaffetilchin Investment Partners, LLC	58,198	2026-03-31
Wealthspire Advisors, LLC	47,498	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BTAI	$0.07	+0.00%	-0.02	$2.28M	0.00%
HYPDHyperion DeFi, Inc.	$3.40	+1.04%	-1.19	$51.54M	0.00%
MAIAMAIA Biotechnology, Inc.	$1.22	+6.09%	-1.88	$74.18M	0.00%
MYOMyomo Inc.	$1.43	+1.42%	-5.02	$55.25M	0.00%
NMTCNeuroOne Medical Technologies Corporation	$1.12	+3.70%	-1.23	$9.75M	0.00%

About electroCore, Inc.

electroCore, Inc. is led by CEO Thomas J. Errico, employs 73 people, headquartered in US, publicly traded since 2018.

electroCore, Inc. (ECOR) stock trades at $9.66 with a market capitalization of $87.09M. The stock is valued at a price-to-earnings (P/E) ratio of -5.72, price-to-book of -32.76, price-to-sales of 2.37. Over the past 52 weeks the stock has ranged between $4.41 and $12.70, and currently trades 23.9% below its 52-week high.

On profitability, electroCore, Inc. generates a return on equity (ROE) of 524.69% — well above the market average, a sign of a high-quality business, return on capital employed of -258.13%, an operating margin of -40.62%, a net profit margin of -39.96%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides